Market revenue in 2023 | USD 6.3 million |
Market revenue in 2030 | USD 10.2 million |
Growth rate | 7.1% (CAGR from 2023 to 2030) |
Largest segment | Echocardiography |
Fastest growing segment | Radionuclide cardiac imaging |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Radionuclide cardiac imaging, Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging |
Key market players worldwide | Toshiba Corporation, Hologic Inc, Carestream Health - HCIS business, GE HealthCare Technologies Inc Common Stock, Siemens Healthineers AG ADR, Koninklijke Philips NV, Hitachi Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-invasive coronary imaging market will help companies and investors design strategic landscapes.
Echocardiography was the largest segment with a revenue share of 30.16% in 2023. Horizon Databook has segmented the France non-invasive coronary imaging market based on radionuclide cardiac imaging, echocardiography, cardiac computed tomography, cardiac magnetic resonance imaging covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing prevalence of chronic diseases such as cancer and the use of parenteral nutrition across the country are majorly driving the market growth. Parenteral nutrition has several benefits such as the fact that it helps in the administration of vital nutrients, thereby maintaining strength, energy, and hydration levels in patients suffering from a disease.
For instance, as per a WHO report, there were around 467,965 new cancer cases in 2020, accounting for 185,621 deaths in the country. IV bags are mainly designed for the packaging of rehydration solutions (glucose, sodium chloride, and lactated Ringer’s solution), parenteral nutrition, and certain antibiotics & analgesics for cancer and other cardiovascular diseases.
Horizon Databook provides a detailed overview of country-level data and insights on the France non-invasive coronary imaging market , including forecasts for subscribers. This country databook contains high-level insights into France non-invasive coronary imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account